4-Hydroxy-5-methylfuran-3(2H)-one
Common Name: |
4-Hydroxy-5-methylfuran-3(2H)-one |
IUPAC Name: |
4-hydroxy-5-methylfuran-3-one |
Molecular Formula: |
C11H18O |
SMILES: |
CC1=C(C(=O)CO1)O |
Inchi: |
1S/C5H6O3/c1-3-5(7)4(6)2-8-3/h7H,2H2,1H3 |
Inchi Key: |
DLVYTANECMRFGX-UHFFFAOYSA-N |
Cas No: |
19322-27-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
166.26 |
Mass (g/mol) |
114.032 |
Molar Refractivity |
52.60 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
4 |
Rings |
1 |
TPSA |
17.07 |
Hetero Atoms |
3 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
126.00 to 133.00 |
Boiling Point (°C@760.00mm Hg) |
215.00 to 217.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.027 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.73 |
LogP |
0.375 |
iLOGP |
2.72 |
XLOGP3 |
3.25 |
WLOGP |
3.25 |
MLOGP |
2.49 |
ESOL Log S |
-2.65 |
ESOL Solubility (mg/ml) |
0.369 |
ESOL Solubility (mol/l) |
0.002 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.28 |
Ali Solubility (mg/ml) |
0.09 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.19 |
Silicos-IT Solubility (mg/ml) |
0.11 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.01 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.531 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
1 |
Acute Oral Toxicity |
2.563 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |